nach oben

International Urology and Nephrology

Erschienen in:

01.12.2009 | Urology - Original Paper

Effects of apocynin and losartan treatment on renal oxidative stress in a rat model of calcium oxalate nephrolithiasis

verfasst von: Cheng-yang Li, Yao-liang Deng, Bing-hua Sun

Erschienen in: International Urology and Nephrology | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Tissue culture studies found that renal epithelial cells suffer oxidative injury on exposure to high levels of oxalate (Ox) and calcium oxalate (CaOx) crystals; nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, a major source of reactive oxygen species (ROS) production in kidney, has been shown to be involved in this event. The present study aimed to investigate whether this in vitro feature of NADPH oxidase could be confirmed in vivo.

Methods

Animal model of nephrolithiasis was established in adult male Sprague-Dawley rats by administration of 0.8% ethylene glycol (EG) in drinking water for 4 weeks. Simultaneous treatment with apocynin (0.2 g kg⁻¹ day⁻¹) or losartan (30 mg kg⁻¹ day⁻¹) by intragastric administration was performed in rats. At the end of the study, urinary 8-IP, a product of lipid peroxidation, and enzymatic activity of superoxide dismutase (SOD) in kidney homogenates were assessed as markers for state of renal oxidative stress (OS). Expression of NADPH oxidase subunit p47phox in kidney was localized and evaluated by immunohistochemistry, real-time polymerase chain reaction (PCR), and Western blotting. The concentration of angiotensin II in kidney homogenates was determined using radioimmunoassay method.

Results

Compared with control, OS developed significantly in rats received EG, with increased expression of p47phox messenger RNA (mRNA) and protein in kidneys. Renal angiotensin II also increased significantly. Treatment with apocynin or losartan significantly reduced excretion of urinary 8-IP, restored SOD activity, with decrease in expression of p47phox in kidney, but levels of those OS markers in apocynin- or losartan-treated rats were still higher than in normal controls.

Conclusions

These results suggest that renal Ang II and its stimulation of NADPH oxidase may partially account for the development of OS in kidney in this rat model of CaOx nephrolithiasis.

Asplin JR (2002) Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am 31:927–949. doi:10.1016/S0889-8529(02)00030-0 CrossRefPubMed

Huang H-S, Ma M-C, Chen J, Chen C-F (2002) Changes in the oxidant–antioxidant balance in the kidneys of rats with nephrolithiasis induced by ethylene glycol. J Urol 167:2584–2593. doi:10.1016/S0022-5347(05)65042-2 CrossRefPubMed

Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and CaOx nephrolithiasis. J Urol 157:1059–1063. doi:10.1016/S0022-5347(01)65141-3 CrossRefPubMed

Huang H-S, Ma M-C, Chen C-F, Chen J (2003) Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 61:1123–1128. doi:10.1016/S0090-4295(03)00764-7 CrossRef

Tungsanga K, Sriboonlue P, Futrakul P, Yachantha C, Tosukhowong P (2005) Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res 33:65–69. doi:10.1007/s00240-004-0444-4 CrossRefPubMed

Chen DH, Kaung HL, Miller CM, Resnick MI, Marengo SR (2004) Microarray analysis of changes in renal phenotype in the ethylene glycol rat model of urolithiasis: potential and pitfalls. BJU Int 94:637–650. doi:10.1111/j.1464-410X.2004.05016.x CrossRefPubMed

Green ML, Freel RW, Hatch M (2005) Lipid peroxidation is not the underlying cause of renal injury in hyperoxaluric rats. Kidney Int 68:2629–2638. doi:10.1111/j.1523-1755.2005.00735.x CrossRefPubMed

Khan SR (2005) Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 33:349–357. doi:10.1007/s00240-005-0492-4 CrossRefPubMed

Thamilselvan S, Menon M (2005) Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int 96:117–126. doi:10.1111/j.1464-410X.2005.05579.x CrossRefPubMed

10.

Umekawa T, Byer K, Uemura H, Khan SR (2005) Diphenyleneiodium (DPI) reduces oxalate ion- and calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells. Nephrol Dial Transplant 20:870–878. doi:10.1093/ndt/gfh750 CrossRefPubMed

11.

Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K (2005) Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol 173:271–275PubMed

12.

Thamilselvan S, Byer KJ, Hackett RL, Khan SR (2000) Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 164:230–236. doi:10.1016/S0022-5347(05)67499-X CrossRef

13.

Thamilselvan S, Khan SR, Menon M (2003) Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3–9PubMed

14.

Selvam R (2002) Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 30:35–49. doi:10.1007/s00240-001-0228-z CrossRefPubMed

15.

Geiszt M, Kopp JB, Varnai P, Leto TL (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 97:8010–8014. doi:10.1073/pnas.130135897 CrossRefPubMed

16.

Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK (2002) NAD(P)H oxidase derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4:899–914. doi:10.1089/152308602762197443 CrossRefPubMed

17.

Griendling KK, Sorescu D, Ushio-Fukai M (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86:494–501PubMed

18.

Babior BM, Lambeth JD, Nauseef W (2002) The neutrophil NADPH oxidase. Arch Biochem Biophys 397:342–344. doi:10.1006/abbi.2001.2642 CrossRefPubMed

19.

Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, Wilcox CS (2005) Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 67:1890–1898. doi:10.1111/j.1523-1755.2005.00287.x CrossRefPubMed

20.

Paliege A, Parsumathy A, Mizel D, Yang T, Schnermann J, Bachmann S (2006) Effect of apocynin treatment on renal expression of COX-2, NOS1, and renin in Wistar-Kyoto and spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 290:R694–R700. doi:10.1152/ajpregu.00219.2005 PubMed

21.

Rashed T, Menon M, Thamilselvan S (2004) Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am J Nephrol 24:557–568. doi:10.1159/000082043 CrossRefPubMed

22.

Umekawa T, Hatanaka YJ, Kurita T, Khan SR (2004) Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15:635–644. doi:10.1097/01.ASN.0000113321.49771.2D CrossRefPubMed

23.

Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F (2001) Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol 166:275–280. doi:10.1016/S0022-5347(05)66144-7 CrossRefPubMed

24.

Toblli JE, Ferder L, Stella I, De Cavanagh MVE, Angerosa M, Inserra F (2002) Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol 168:1550–1555. doi:10.1016/S0022-5347(05)64519-3 CrossRefPubMed

25.

Khand FD, Gordge MP, Robertson WG, Noronha-Dutra AA, Hothersall JS (2002) Mitochondrial superoxide production during oxalate mediated oxidative stress in renal epithelial cells. Free Radic Biol Med 32:1339–1350. doi:10.1016/S0891-5849(02)00846-8 CrossRefPubMed

26.

Cao L-C, Honeyman TW, Cooney R, Kennington L, Scheid CR, Jonassen JA (2004) Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 66:1890–1900. doi:10.1111/j.1523-1755.2004.00963.x CrossRefPubMed

27.

Engels F, Renirie BF, Hart BA, Labadie RP, Nijkamp FP (1992) Effects of apocynin, a drug isolated from the roots of Picrorhiza kurroa, on arachidonic acid metabolism. FEBS Lett 305:254–256. doi:10.1016/0014-5793(92)80680-F CrossRefPubMed

28.

Aihara K, Byer KJ, Khan SR (2003) Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int 64:1283–1291. doi:10.1046/j.1523-1755.2003.00226.x CrossRefPubMed

29.

Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS (2002) Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB. Kidney Int 61:186–194. doi:10.1046/j.1523-1755.2002.00123.x CrossRefPubMed

30.

Morrow JD, Roberts LJ (1997) The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 36:1–21. doi:10.1016/S0163-7827(97)00001-5 CrossRefPubMed

31.

Khan SR, Glenton PA, Byer KJ (2006) Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxyl-L-proline. Kidney Int 165:1173–1181

32.

Ueda N, Kaushal GP, Shah SV (2000) Apoptotic mechanisms in acute renal failure. Am J Med 108:403–415. doi:10.1016/S0002-9343(00)00311-9 CrossRefPubMed

33.

Gill PS, Wilcox CS (2006) NADPH oxidases in the kidney. Antioxid Redox Signal 8:1597–1607. doi:10.1089/ars.2006.8.1597 CrossRefPubMed

34.

Shiose A, Kuroda J, Tsuruya K (2001) A novel superoxide producing NADPH oxidase in kidney. J Biol Chem 276:1417–1423. doi:10.1074/jbc.M007597200 CrossRefPubMed

35.

Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS (2002) Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39:269–274. doi:10.1161/hy0202.103264 CrossRefPubMed

36.

Li JM, Shah AM (2003) ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 14:S221–S226. doi:10.1097/01.ASN.0000077406.67663.E7 CrossRefPubMed

37.

Yasunari K, Maeda K, Nakamura M, Yoshikawa J (2002) Pressure promotes angiotensin II-mediated migration of human coronary smooth muscle cells through increase in oxidative stress. Hypertension 39:433–437. doi:10.1161/hy02t2.102991 CrossRefPubMed

38.

Lavigne MC, Malech HL, Holland SM, Leto TL (2001) Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation 104:79–84. doi:10.1161/hc4001.096828 CrossRefPubMed

39.

Seikaly MG, Aarnt BS Jr, Seney FD Jr (1990) Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 86:1352–1357. doi:10.1172/JCI114846 CrossRefPubMed

40.

Antus B, Exton MS, Rosivall L (2001) Angiotensin II. A regulator of inflammation during renal disease? Int J Immunopathol Pharmacol 14:25–30PubMed

41.

Tojo A, Onozato ML, Kobayashi N, Goto A, Matsuoka H, Fujita T (2002) Angiotensin II and oxidative stress in Dahl Salt-sensitive rat with heart failure. Hypertension 40:834–839. doi:10.1161/01.HYP.0000039506.43589.D5 CrossRefPubMed

Titel: Effects of apocynin and losartan treatment on renal oxidative stress in a rat model of calcium oxalate nephrolithiasis
verfasst von: Cheng-yang Li
Yao-liang Deng
Bing-hua Sun
Publikationsdatum: 01.12.2009
Verlag: Springer Netherlands
Erschienen in: International Urology and Nephrology / Ausgabe 4/2009
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-009-9534-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2009

Growth pattern in superficial urothelial bladder carcinomas. Histological review and clinical relevance

Editorial comment

Normotensive ischemic acute kidney injury as a manifestation of intra-abdominal hypertension

Patterns of cardioprotective medication prescription in incident hemodialysis patients

The effects of neoadjuvant chemotherapy and chemo-radiation therapy on MRI staging in invasive bladder cancer: comparative study based on the pathological examination of whole layer bladder wall